Vrillon, Agathe http://orcid.org/0000-0002-0761-7885
Ashton, Nicholas J.
Karikari, Thomas K.
Götze, Karl
Cognat, Emmanuel
Dumurgier, Julien
Lilamand, Matthieu
Zetterberg, Henrik
Blennow, Kaj
Paquet, Claire
Funding for this research was provided by:
Fondation Ophtalmologique Adolphe de Rothschild
Fondation Philippe Chatrier
Association Amicale des Anciens Internes des Hopitaux de Paris
Fondation Vaincre Alzheimer
Demensfonden
Gun och Bertil Stohnes Stiftelse
Stiftelsen för Gamla Tjänarinnor
Wallenberg Centre for Molecular and Translational Medicine
Alzheimerfonden (AF-940244)
Hjärnfonden (FO2021-0298)
BrightFocus Foundation (A2020812F)
International Society for Neurochemistry’s Career Development Grant
Demensförbundet
Parkinsonfonden
Aina Wallströms and Mary-Ann Sjöbloms Foundation
Agneta Prytz-Folkes och Gösta Folkes Stiftelse (2020-00124)
Anna-Lisa och Bror Björnssons Stiftelse
H2020 European Research Council (2018-02532)
Swedish State Support for Clinical Research (ALFGBG-720931)
Alzheimer's Drug Discovery Foundation (201809-2016862)
AD Strategic Fund and the Alzheimer’s Association (ADSF-21-831376-C)
Olav Thon Stiftelsen
Familjen Erling-Perssons Stiftelse
HORIZON EUROPE Marie Sklodowska-Curie Actions (860197)
UK Dementia Research Institute
Article History
Received: 20 July 2023
Revised: 11 October 2023
Accepted: 13 October 2023
First Online: 11 November 2023
Declarations
:
: HZ has served at scientific advisory boards for Alector, Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies and CogRx, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). CP is a member of the International Advisory Boards of Lilly; is a consultant for Fujiribio, Alzhois, Neuroimmune, Ads Neuroscience, Roche, AgenT and Gilead; and is involved as an investigator in several clinical trials for Roche, Esai, Lilly, Biogen, Astra-Zeneca, Lundbeck, and Neuroimmune. KB has served as a consultant and at advisory boards for Acumen, ALZPath, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served at data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Progra (outside submitted work).
: This research study was approved by the local ethics committee of Bichat Hospital, Paris, France (CEERB GHU Nord no.10-037).
: Informed consent was obtained from the patients who participated in the study.